EcoDrugPlus

Transthyretin

Ensembl ID : ENSBMUG00000012078
Gene Symbol: TTR
3 Cross references
166 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSBMUG00000018029
Gene Symbol: TPH1
3 Cross references
257 Possible Orthologues:

Tubulin Alpha 1a

Ensembl ID : ENSBMUG00000023218
Gene Symbol: TUBA1A
3 Cross references
87 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSBMUG00000026111
Gene Symbol: TUBA4A
3 Cross references
225 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSBMUG00000019392
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSBMUG00000011520
Gene Symbol: TUBB3
1 Cross references
154 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSBMUG00000000367
Gene Symbol: TUBB4A
3 Cross references
89 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSBMUG00000026026
Gene Symbol: TUBB4B
3 Cross references
178 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSBMUG00000010971
Gene Symbol: TUBB6
3 Cross references
141 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSBMUG00000020175
Gene Symbol: LOC102285043
2 Cross references
229 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSBMUG00000007738
Gene Symbol: TUBB
2 Cross references
95 Possible Orthologues:

Tubulin Beta-2b Chain

Ensembl ID : ENSBMUG00000009966
Gene Symbol: LOC102281195
2 Cross references
148 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).